Breakthrough Optical Biosensor for Rapid Mpox Detection: A Game-Changer in Epidemic Management

**Mpox Outbreak and Diagnostic Challenges** Since 2023, a new variant of human mpox has spread from the Democratic Republic of the Congo, claiming lives and spreading internationally. The outbreak has been declared a Public Health Emergency by the WHO, pointing to the pressing need for rapid, cost-effective diagnostic tools to combat it. Traditional PCR methods, while accurate, are slow and costly, making swift epidemic responses challenging. **Innovative Solution: Optical Biosensor** Researchers from University of California School of Medicine and Boston University have created an optical biosensor that uses a technology known as Pixel-Diversity Interferometric Reflectance Imaging Sensor (PD-IRIS) to detect monkeypox rapidly. This tool can distinguish mpox from other viruses with similar symptoms, like herpes simplex and cowpox, in under 20 minutes. **Technical Insight** Using precise wavelengths of red and blue light, the biosensor analyzes virus-antibody complexes fixed onto silicon chips, leveraging interference patterns to identify the presence of the virus with high specificity. This process is akin to FM radio, amplifying a weak signal using a strong carrier frequency. **Impact and Future Aspirations** The rapid diagnosis capability of this biosensor not only aids in managing the current outbreak but also prepares healthcare systems for future pandemics. Researchers aim to commercialize this technology, making it adaptable for multiple viruses like HIV using the same chip with different antibodies. This endeavor, however, requires governmental support due to limited market incentives for preemptive diagnostics.